Skip to main content
SpringerLink
Log in

Discussion

  • Chapter
  • First Online:
Vaccination of Immunosuppressed Children in Clinical Practice

Part of the book series: In Clinical Practice ((ICP))

  • 182 Accesses

Abstract

Overall, there are many studies assessing the vaccination of children with dysimmune disorders or after transplantation [1–12]. All published studies are very reassuring from a safety point of view and most vaccines appear to be safe in children on immunosuppressive treatment. They do not frequently cause serious adverse events and do not increase disease activity or induce rejection. However, there are only a few studies that have assessed vaccination with live vaccines in this patient population [7–43].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bijl M, Agmon-Levin N, Dayer JM, Israeli E, Gatto M, Shoenfeld Y. Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment. Autoimmun Rev. 2012;11(8):572–6.

    Article  CAS  PubMed  Google Scholar 

  2. Heijstek MW, Ott de Bruin LM, Borrow R, van der Klis F, Kone-Paut I, Fasth A, et al. Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations. Autoimmun Rev. 2011;11(2):112–22.

    Article  CAS  PubMed  Google Scholar 

  3. Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Kone-Paut I, et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis. 2011;70(10):1704–12.

    Article  CAS  PubMed  Google Scholar 

  4. Blanchard-Rohner G. Vaccination in children with autoimmune disorders and treated with various immunosuppressive regimens: a comprehensive review and practical guide. Front Immunol. 2021;12:711637.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Akikusa JD, Crawford NW. Vaccination in paediatric rheumatology. Curr Rheumatol Rep. 2014;16(8):432.

    Article  PubMed  Google Scholar 

  6. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44–100.

    Article  PubMed  Google Scholar 

  7. Keller M, Pittet LF, Zimmermann P. Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment – a systematic review. Eur J Pediatr. 2021:1–34.

    Google Scholar 

  8. Pittet LF, Posfay-Barbe KM. Vaccination of immune compromised children-an overview for physicians. Eur J Pediatr. 2021;180(7):2035–47.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Patel S, Heath P, Skinner R. Vaccinations for paediatric patients treated with standard-dose chemotherapy and hematopoietic stem cell transplantation (HSCT) recipients. UK: Children’s Cancer and Leukaemia Group; 2016. [updated Sept 2017, Feb 2020]. https://www.cclg.org.uk/write/MediaUploads/Member%20area/Treatment%20guidelines/Vaccinations_for_Children_treated_with_Standard-dose_Chemotherapy_and_HSCT_Recipients-Sept_2014-FINAL_CCLG.pdf

  10. Ljungman P, Cordonnier C, Einsele H, Englund J, Machado CM, Storek J, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2009;44(8):521–6.

    Article  CAS  PubMed  Google Scholar 

  11. Robinson CL, Bernstein H, Poehling K, Romero JR, Szilagyi P. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger – United States, 2020. MMWR. 2020;69(5):130–2.

    PubMed  PubMed Central  Google Scholar 

  12. Suresh S, Upton J, Green M, Pham-Huy A, Posfay-Barbe KM, Michaels MG, et al. Live vaccines after pediatric solid organ transplant: proceedings of a consensus meeting, 2018. Pediatr Transplant. 2019:e13571.

    Google Scholar 

  13. Borte S, Liebert UG, Borte M, Sack U. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford). 2009;48(2):144–8.

    Article  CAS  Google Scholar 

  14. Heijstek MW, Kamphuis S, Armbrust W, Swart J, Gorter S, de Vries LD, et al. Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA. 2013;309(23):2449–56.

    Article  CAS  PubMed  Google Scholar 

  15. Maritsi DN, Kopsidas I, Vartzelis G, Spyridis N, Tsolia MN. Long-term preservation of measles and rubella specific-IgG antibodies in children with enthesitis related arthritis on anti-TNFalpha treatment: a prospective controlled study. Rheumatology (Oxford). 2019;58(9):1686–8.

    Article  Google Scholar 

  16. Pileggi GS, de Souza CB, Ferriani VP. Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids. Arthritis Care Res. 2010;62(7):1034–9.

    Article  CAS  Google Scholar 

  17. Barbosa CM, Terreri MT, Rosario PO, de Moraes-Pinto MI, Silva CA, Hilario MO. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus. Clin Exp Rheumatol. 2012;30(5):791–8.

    PubMed  Google Scholar 

  18. Toplak N, Avcin T. Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy. Vaccine. 2015;33(33):4056–9.

    Article  CAS  PubMed  Google Scholar 

  19. Groot N, Pileggi G, Sandoval CB, Grein I, Berbers G, Ferriani VPL, et al. Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment. Vaccine. 2017;35(21):2818–22.

    Article  CAS  PubMed  Google Scholar 

  20. Speth F, Hinze CH, Andel S, Mertens T, Haas JP. Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list. Pediatr Rheumatol Online J. 2018;16(1):15.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Zamora I, Simon JM, Da Silva ME, Piqueras AI. Attenuated varicella virus vaccine in children with renal transplants. Pediatr Nephrol. 1994;8(2):190–2.

    Article  CAS  PubMed  Google Scholar 

  22. Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J Pediatr. 1993;123(1):87–9.

    Article  CAS  PubMed  Google Scholar 

  23. Kano H, Mizuta K, Sakakihara Y, Kato H, Miki Y, Shibuya N, et al. Efficacy and safety of immunization for pre- and post-liver transplant children. Transplantation. 2002;74(4):543–50.

    Article  CAS  PubMed  Google Scholar 

  24. Khan S, Erlichman J, Rand EB. Live virus immunization after orthotopic liver transplantation. Pediatr Transplant. 2006;10(1):78–82.

    Article  PubMed  Google Scholar 

  25. Shinjoh M, Miyairi I, Hoshino K, Takahashi T, Nakayama T. Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine. 2008;26(52):6859–63.

    Article  PubMed  Google Scholar 

  26. Shinjoh M, Hoshino K, Takahashi T, Nakayama T. Updated data on effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine. 2015;33(5):701–7.

    Article  PubMed  Google Scholar 

  27. Gerner P, Lainka E, Ballauff A, Gierenz N, Hoyer P. Immunization with the measles-mumps-rubella vaccine in children before and after liver transplantation. Z Gastroenterol. 2009;47(09):P098.

    Google Scholar 

  28. Kawano Y, Suzuki M, Kawada J, Kimura H, Kamei H, Ohnishi Y, et al. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Vaccine. 2015;33(12):1440–5.

    Article  CAS  PubMed  Google Scholar 

  29. Pittet LF, Verolet CM, McLin VA, Wildhaber BE, Rodriguez M, Cherpillod P, et al. Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation. Am J Transplant. 2018.

    Google Scholar 

  30. Pauksen K, Duraj V, Ljungman P, Sjolin J, Oberg G, Lonnerholm G, et al. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant. 1992;9(6):427–32.

    CAS  PubMed  Google Scholar 

  31. Shaw PJ, Bleakley M, Burgess M. Safety of early immunization against measles/mumps/rubella after bone marrow transplantation. Blood. 2002;99(9):3486.

    Article  CAS  PubMed  Google Scholar 

  32. Machado CM, de Souza VA, Sumita LM, da Rocha IF, Dulley FL, Pannuti CS. Early measles vaccination in bone marrow transplant recipients. Bone Marrow Transplant. 2005;35(8):787–91.

    Article  CAS  PubMed  Google Scholar 

  33. Small TN, Iovino CS, Abboud M, Lubin M, Papadopoulos E, Scaradavou A, et al. Vaccine response in recipients of HLA mismatched unrelated double unit cord blood transplantation (CBT). Am Soc Hematol. 2010.

    Google Scholar 

  34. Levitsky J, Te HS, Faust TW, Cohen SM. Varicella infection following varicella vaccination in a liver transplant recipient. Am J Transplant. 2002;2(9):880–2.

    PubMed  Google Scholar 

  35. Chaves Tdo S, Lopes MH, de Souza VA, Dos Santos SS, Pereira LM, Reis AD, et al. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients. Pediatr Transplant. 2005;9(2):192–6.

    PubMed  Google Scholar 

  36. Weinberg A, Horslen SP, Kaufman SS, Jesser R, Devoll-Zabrocki A, Fleckten BL, et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant. 2006;6(3):565–8.

    CAS  PubMed  Google Scholar 

  37. Kraft JN, Shaw JC. Varicella infection caused by Oka strain vaccine in a heart transplant recipient. Arch Dermatol. 2006;142(7):943–5.

    PubMed  Google Scholar 

  38. Posfay-Barbe KM, Pittet LF, Sottas C, Grillet S, Wildhaber BE, Rodriguez M, et al. Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic. Am J Transplant. 2012;12(11):2974–85.

    Article  CAS  PubMed  Google Scholar 

  39. Verolet CM, Pittet LF, Wildhaber BE, McLin VA, Rodriguez M, Grillet S, et al. Long-term seroprotection of varicella-zoster immunization in pediatric liver transplant recipients. Transplantation. 2019;103(11):e355–e64.

    Article  PubMed  Google Scholar 

  40. Sauerbrei A, Prager J, Hengst U, Zintl F, Wutzler P. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant. 1997;20(5):381–3.

    CAS  PubMed  Google Scholar 

  41. Ljungman P, Wang FZ, Nilsson C, Solheim V, Linde A. Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study. Support Care Cancer. 2003;11(11):739–41.

    Article  CAS  PubMed  Google Scholar 

  42. Kussmaul SC, Horn BN, Dvorak CC, Abramovitz L, Cowan MJ, Weintrub PS. Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs. Bone Marrow Transplant. 2010;45(11):1602–6.

    CAS  PubMed  Google Scholar 

  43. Chou JF, Kernan NA, Prockop S, Heller G, Scaradavou A, Kobos R, et al. Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT). Biol Blood Marrow Transplant. 2011;17(11):1708–13.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Paediatrics, Immunology-Vaccinology, Geneva University Hospitals, Geneva, Switzerland

    Geraldine Blanchard-Rohner & Laure F. Pittet

Authors
  1. Geraldine Blanchard-Rohner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laure F. Pittet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Geraldine Blanchard-Rohner .

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Blanchard-Rohner, G., Pittet, L.F. (2022). Discussion. In: Vaccination of Immunosuppressed Children in Clinical Practice . In Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-031-04844-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-04844-9_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-04843-2

  • Online ISBN: 978-3-031-04844-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation